Stony Brook University Hospital — Stony Brook, New York

Public research footprint of Stony Brook University Hospital, compiled from the ClinicalTrials.gov public registry.

207

Registered studies

Active

Recruiting now

104

Completed

Stopped or withdrawn

Most-studied conditions

B-cell Non-Hodgkin Lymphoma (B-NHL) · Diffuse Large B-cell Lymphoma (DLBCL) · Multiple Myeloma/ Plasma Cell Disorder (PCD) · Locally Advanced Breast Cancer

Recently updated registry entries

NCT06305780 — RECOVER-AUTONOMIC Platform Protocol (Completed)
NCT03888105 — A Study to Assess the Anti-Tumor Activity and Safety of Odronextamab in Adult Patients… (Active Not Recruiting)
NCT04763200 — Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Stony Brook University Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.